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Background. Metabolic Syndrome (MetS) is a major public health concern. Objective. The aim of this study was to estimate the
frequency of MetS, its components, and factors associated with MetS amongst apparently healthy individuals in Pakistan.Methods.
A retrospective cross-sectional study was conducted at the executive Clinics of Aga Khan Hospital, Pakistan. Medical records of
patients aged ≥18 years visiting the clinics from July 2011 to December 2011 were consecutively reviewed. Records in which either
MetS components data or 10% of overall data was missing were excluded. A total of 1329 participants’ records was included in final
analysis. Data was analyzed using SPSS version 19 and multivariable logistic regression was used to identify the factors associated
with MetS. Results. A total of 847 (63.7%) participants had MetS; mean age of the participants were 47.6 ± 11.6 years. About
70.4% were males and 29.6% were females. Approximately 70% of participants had BMI ≥25 kg/m2. MetS was associated with
male gender (AOR= 2.1; 95%C.I: 1.6–3.2) and history of diabetes among parents (AOR= 3.0; 95%C.I: 1.6–6.0). Conclusion. This
study shows that a large proportion of population has MetS and is overweight or obese. This requires urgent interventions on
part of health care providers’ especially family physicians. Educating masses about life style factors can make a diﬀerence. Further
researches on this issue are warranted.
1. Introduction
Globally, Metabolic Syndrome (MetS) has become a public
health concern and is a major cause of morbidity and
mortality. Many studies have provided strong evidence for
the association of MetS with acute coronary syndrome [1–
4]. In health care services the value of MetS derives largely
from its potential to reduce the risk of cardiovascular disease
in the general population by treating the disease [5].
There has been much a debate on the definition of
MetS. However, recent definition of MetS given by American
heart association and the National heart, Lung and Blood
Institute (AHA/NHLBI) in 2005 declared that a clinical
diagnosis of MetS can be established if any three of the
following factors are present, elevated triglyceride level (TG):
elevated waist circumference, decreased HDL-cholesterol
(HDL) level, elevated fasting glucose, and elevated blood
pressure [6].
The estimated prevalence of MetS in general population
is between 17 and 25% [7]. Various studies have demon-
strated that the major causes leading to MetS are insulin
resistance, obesity, and genetic predisposition [8]. Several
cross-sectional studies have established that overweight and
obesity are clearly associated with risk factor components
that make up MetS [9].
A recent study from Sweden has shown that presence of
MetS can give essential prognostic information of cardiovas-
cular mortality if the current status of risk factors is known
in an individual [2]. Recently questions have been raised
about the role of MetS as a separate entity, associated with
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a greater risk of development of cardiovascular disease. Indo-
Asian population has highest risk of developing coronary
artery disease in the world, thus it is not surprising that it
has become a common cause of death in this subcontinent
[10, 11]. With increasing urbanization the risk of developing
MetS and its associated risk factors like ischemic heart disease
is only likely to show an upward trend.
The incidence of Type 2 Diabetes Mellitus (T2DM) has
been increasing in the last decades and is projected to rise
from 171 million in 2000 to 366 million in 2030 [12]. In
Pakistan, about 10% of adult population is having diabetes,
ranking sixth with an increasing trend [13]. It is projected
that if the situation persists, by the year 2030 Pakistan will
rank the 4th in the world for the burden of diabetes [13].
Several population studies have indicated that metabolic syn-
drome is a risk factor for the development of T2DM [8, 14,
15].
Studies have shown that unlike European countries the
risk of developing cardiovascular disease and its associated
risk factors like hypertension, dyslipidemia is nearly equiv-
alent among men and women in Asian countries [16]. A
very often occurring point in the prevalence of MetS is that
it shows age dependence whereas its prevalence has been
shown to increase with increasing age [17]. Among South
Asians cardiovascular risk factors are seen at a younger age
and the reason for this is still unclear [18].
Recently some controversies were raised by Kahn regard-
ing the definition of MetS which implies that the factors
included in the definition of MetS should have greater pre-
dictive power than all other combinations [19]. Nonetheless,
there is no obvious evidence which shows this.
Family physicians/general practitioners mainly focuse
on holistic and integrated care with health promotion and
disease prevention: the core of their practice. Usually they are
the first contact with the patients, hence, awareness regarding
MetS and the individual risk of each component is vital so
that individualized treatment/prevention strategies can be
implemented. Therefore, this study was designed to estimate
the frequency of MetS, its components, factors associated,
and clustering of diﬀerent components of MetS amongst
apparently healthy individuals in Pakistan.
2. Material and Methods
A retrospective cross sectional study was done at the exec-
utive Clinics of the Aga Khan University Hospital Karachi,
Pakistan (AKUH). The Aga Khan University is a not-for-
profit, tertiary care hospital. Medical records of all patients
aged 18 years onwards who came for their routine annual
physical checkups over a period of six months at executive
clinics of AKUH from July 2011 to December 2011 were
consecutively reviewed. Patients for which either MetS com-
ponents (BMI, FBS, HDL, BP, TRIG) data or 10% of overall
data was missing were excluded from the study. A total of
1500 medical records were reviewed. 171 patients’ data were
incomplete and therefore were excluded and remaining 1329
patients’ records were included in final analysis.
The routine examination at the executive clinics, AKUH,
includes a detailed physical examination comprising height,
weight, blood pressure, thorough general and physical
examination along with complete blood picture, erythrocyte
sedimentation rate, fasting blood sugar, lipid profile, liver
function tests, creatinine, uric acid, chest X-ray, and ECG.
A structured questionnaire was formulated to extract the
information. These questionnaires were filled by a medical
graduate specifically trained for the task and it was composed
of two sections. Section A included questions on demo-
graphic detail of the participants (age, gender). Section B
dealt with the risk factors ofMetS including BMI, blood pres-
sure, fasting blood sugar, triglycerides, and HDL. This sec-
tion also included questions on family history of CVD among
parents, sibling, and children. The study was reviewed and
approved by the Family Medicine’s Departmental Research
Committee of The Aga Khan University Hospital, Karachi,
Pakistan.
According to the new International Diabetes Federation
definition, for a person to be defined as having the metabolic
syndrome they must have the following [20].
Central Obesity. Males ≥90 cm and females ≥80 cm (based
on Asian Indian, Malay & Chinese population). The new
International Diabetes Federation definition suggests that If
BMI is >30 kg/m2, central obesity can be assumed and waist
circumference does not need to be measured. In this study
we used Asian cutoﬀ for obesity that is, ≥25 kg/m2.
Also they must have any two of the following four
factors:
(1) raised triglycerides: ≥150mg/dL (1.69mmol/L);
(2) reduced HDL cholesterol: <40mg/dL (1.04mmol/L)
in men and <50mg/dL (1.29mmol/L) in women;
(3) raised blood pressure: ≥130/85mm Hg;
(4) raised plasma fasting glucose: ≥100mg/dL (≥6.1
mmol/L).
Statistical analysis was carried out using SPSS software (Sta-
tistical Package for the Social Sciences, version 17). Propor-
tions were reported for all the variables such as age, gender,
and components of MetS. Univariate and multivariate
logistic regression was done to identify the factors associated
withMetS. The results are reported in form of odds ratio and
95% confidence intervals. A P value of <0.05 was considered
statistically significant throughout the study.
3. Results
A total of 1329 patients’ records were included in the final
analysis and for missing data we averaged estimates of the
variables to give a single mean estimate. The medical record
indicates that out of the total patients 936 (70.5%) were
males and 393 (29.5) were females. The mean age of the
patients was 47.6 ± 11.6 years.
Table 1(a) depicts the age- and gender-specific percent-
ages of individual component of MetS. A total of 847
participants had MetS, thus showing a prevalence of 63.7%.
Almost 70% of the patients had BMI over 25. As com-
pared to females, males had higher prevalence of BMI over
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Table 1: Age and gender specific prevalence of individual components of MetS among 1329 participants.
(a) Total population
Parameter
Total population Men only Women only
P value
N = 1329 N = 936 N = 393
Age∗ 47.6 (±11.6)∗ 936 (70.5) 393 (29.5) 0.13
% BMI: ≥ 25 kg/m2 934 (70.3) 654 (70.0) 280 (30.0) 0.61
% raised triglycerides 532 (41.6) 399 (75.0) 133 (25.0) 0.02
% reduced HDL cholesterol 715 (58.7) 478 (66.9) 237 (33.1) <0.001
% raised blood pressure 729 (54.9) 536 (73.5) 193 (26.5) 0.006
% raised plasma fasting glucose 834 (63.4) 624 (74.8) 210 (25.2) <0.001
∗
Mean (standard deviation), N : number (percentage).
P-value: diﬀerence in males and females, significance at <0.05.
BMI: ≥ 25 kg/m2.
Raised triglycerides: ≥150mg/dL (1.69 mmol/L).
Reduced HDL cholesterol: <40mg/dL (1.04mmol/L) in men, <50mg/dL (1.29mmol/L) in women.
Raised blood pressure: ≥130/85mm Hg.
Raised plasma fasting glucose: ≥100mg/dL (≥6.1mmol/L).
(b) Age less than 40 years
Parameter
Total population Men only Women only
P-value
N(%) N(%) N(%)
Age < 40 years 323 (24.3) 222 (68.7) 101 (31.3) 0.44
BMI ≥ 25 kg/m2 218 (67.5) 157 (72.0) 61 (28.0) 0.04
Raised triglycerides 109 (34.8) 131 (75.2) 73 (24.8) 0.03
Reduced HDL cholesterol 195 (63.7) 128 (65.6) 67 (34.4) 0.04
Raised blood pressure 127 (39.3) 105 (82.7) 22(17.3) <0.001
Raised plasma fasting glucose 135 (42.2) 108 (80.0) 27 (20.0) <0.001
N : number (percentage).
P-value: diﬀerence in males and females, significance at <0.05.
(c) Age more than 40 years
Parameter
Total population Men only Women only
P-value
N(%) N(%) N(%)
Age > 40 years 1006 (75.7) 714 (71.0) 292 (29.0) 0.44
% BMI: ≥ 25 kg/m2 716 (71.2) 497 (69.4) 219 (30.6) 0.05
% Raised triglycerides 423 (43.8) 317 (74.9) 106 (25.1) 0.02
% Reduced HDL cholesterol 520 (57.0) 350 (67.3) 170 (32.7) <0.001
% Raised blood pressure 602 (59.8) 431 (71.6) 171 (28.4) 0.59
% Raised plasma fasting glucose 699 (70.2) 516 (73.8) 183 (26.2) 0.002
N : number (percentage).
P-value: diﬀerence in males and females, significance at <0.05.
25 (70% v/s 30%). Over two-thirds of the patients had raised
plasma blood glucose. However, one-third (33%) of the total
female population had reduced HDL levels.
Table 1(b) shows the age- (less than 40 years) and gender-
specific component of MetS. In all, 23.3% of the populations
were aged less than 40 years, with 68.1% males and the
rest were females. About 34.8% of the patients had raised
triglyceride levels, while 65.6% of the males and 34.4% of the
females less than 40 years had reducedHDL levels (P = 0.04).
The P-values were significant for all components, suggesting
there was significant diﬀerence among males and females
with respect to the components of MetS.
Table 1(c), presents the age and sex specific distribution
of components of MetS, who are more than 40 years old.
About three fourth of the total patient population were more
than 40 years of age. Majority of the patients (71.7%) had
BMI >25 and all the results were statistically significant at
5% significance level (P < 0.05) except raised blood pressure
(P = 0.59).
The association of demographic and family factors with
MetS is presented in Table 2. The odds of having MetS were
2 times higher among males (AOR: 2.1; 95% C.I: 1.6–3.2) as
compared to females. Those patients who had past history of
diabetes were 5 times at risk of developing MetS as compared
to others when adjusted for other variables in the model
(AOR: 5.3; 95% CI: 1.0–74) and was highly significant (P <
0.001). About 60% of the patients who had MetS had family
history of diabetes among parents, while about two-third
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Table 2: Univariate and multivariable logistic regression analysis of factors associated with MetS.
Variable
MS present
N = 847
(63.7)
MS absent
N = 482
(36.3)
Unadjusted odds
ratio (95% C.I)
Adjusted odds
ratio (95% CI)
P value
Gender
Female 227 (57.8) 166 (42.2) 1 1
0.003
Male 620 (66.2) 316 (33.8) 1.4 (1.1–1.8) 2.1 (1.6–3.2)
Educational statusC
University level 242 (28.6) 97 (20.2) 1 1
Secondary level 255 (30.0) 179 (37) 1.5 (1.3–1.8) 2.2 (1.5–3.2) 0.01
Primary level 350 (41.4) 206 (42.8) 2.0 (1.4–2.8) 3.0 (2.4–3.8)
Past history of diabetes
No 483 (57) 294 (61) 1 1
<0.001
Yes 364 (43) 188 (39) 3.3 (2.20–4.6) 5.3 (1.0–74)
Family history of diabetes of parents
No 338 (40.0) 146 (30.4) 1 1
0.04
Yes 509 (60.0) 336 (69.6) 2.3 (1.2–4.0) 3.0 (1.6–6.0)
Family history of diabetes of sibling
No 295 (34.8) 145 (30) 1 1
0.03
Yes 552 (65.1) 337 (70) 1.4 (1.2–1.6) 2.4 (1.0–4.8)
Family history of CVD of parents
No 232 (27.5) 366 (76.1) 1 1
NS
Yes 615 (72.5) 116 (23.9) 1.5 (0.5–4.5) 6.9 (0.8–8.4)
Family history of CVD of sibling
No 289 (34.2) 184 (38.2) 1 1
NS
Yes 558 (65.8) 298 (61.8) 4.4 (0.8–6.4) 6.0 (4.7–7.8)
95% CI: 95% confidence interval, NS: not significant at P value <0.05. Educational StatusC: university level (14 years or more), secondary level (6–12 years
of education), and primary level (1–5 years of education).
MetS patients had family history of diabetes among siblings
(AOR: 3.0; 95% C.I: 1.6–6.0). The other variables which were
statistically insignificant at the multivariate regression were
family history of CVD among parents and siblings. About
41% of the patients who had MetS; had 5 or less years of
education and the maximum risk was also observed amongst
them (AOR: 3.0; 95% CI: 2.4–3.8).
The pattern of appearance of MetS components among
study participants is depicted in Figure 1. Only 2.6% of the
participants had no risk factor of MetS, while around 11% of
the participants had 5 or more risk factors. Almost 30% of
the participants had 3 risk factors, whereas, 10% and 21% of
the participants had 1 and 2 risk factors of MetS respectively.
4. Discussion
In this study the prevalence of MetS was found to be 63.7%
among the study participants. The results also highlight that
BMI over 25 was the most common (70.3%) risk factor
present among the cases of MetS. This prevalence of MetS
is almost twice as high as in the United States as determined
in NHANES data [21]. The major reason for this variation
can be the fact that in this study we used BMI ≥25 kg/m2
for diagnosis of MetS and due to this a large proportion
of participants were included in the definition of MetS.
According to IDF, a BMI cutoﬀ of ≥30 kg/m2 can be used for
diagnosing MetS [20], nonetheless in Asian population the
cutoﬀ for obesity is ≥25 kg/m2, which was used in this study
[22]. However, Asian cutoﬀ of BMI for diagnosis of diabetes
and CVD is ≥23 kg/m2 due to the diﬀerence in adiposity, as
Asians tend to have more central obesity than other pop-
ulations [22]. Though analysis was also performed at BMI
cutoﬀ of ≥23 kg/m2 to observe any change in the prevalence
of MetS. Nonetheless there was no diﬀerence in prevalence of
MetS when the cutoﬀ ≥23 kg/m2 was used.
The prevalence of MetS in Pakistan is showing an upward
trend [23]. The results of this study cannot be compared
to other studies conducted in Pakistan. As these studies
have shown contrasting prevalence of MetS ranging from
as low as 20% and as high as 85% [23–25], there were dif-
ferences in definitions of MetS and population selection,
that is, participants with comorbidities such as T2DM. A
study by Mohsin et al. found a high prevalence of 85% and
was conducted on type 2 diabetics [25]. Results from other
populations reported the prevalence to be between 70 to
80% among Caucasians with T2DM [26] and 75.6% among
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Figure 1: Pattern of appearance of MetS components among study
participants.
Chinese diabetics [27]. This high prevalence 63.4% of MetS
that we observe in the study can be attributed to 43% of the
patients who had past history of T2DM.
It is well reported that the risk factors which are most
frequently present in MetS cases include obesity, coronary
heart disease, sedentary lifestyle, aging, and lipodystrophy
[28, 29].
Various studies reveal that the components which make
up MetS vary in the rates in which they occur in diﬀerent
populations [18, 19]. The Seychelles study conducted on
1255 participants reported that adiposity and high blood
pressure are most common occurring components of MetS
[30]. However, in the present study BMI in 70% and high
fasting blood glucose in 62% of the study participants were
the most prevalent components. This is not surprising as it
has been evident that central obesity precedes the appearance
of other MetS components and it also plays a crucial role
in the development of MetS [31]. Moreover, in Asian pop-
ulation central obesity is found to be more common [22]. An
analysis of the National Health Survey of Pakistan revealed
that 25% of our population is obese [22]. Latest researches
have now shown that although obesity is an intriguing factor
of MetS there are some phenotypes which alters this defi-
nition [32]. Despite having BMI exceeding 30 kg/m2, indi-
viduals are relatively insulin sensitive and lack most of the
metabolic abnormalities typical of obese individuals [32].
These individuals’ phenotypes separate obesity from its usual
metabolic consequences and demandsmore focus on cluster-
ing of the risk factors.
The incidence of T2DM worldwide is rising exponen-
tially due to increase in sedentary life style leading to central
abdominal obesity [22]. T2DM is one of the most common
chronic diseases worldwide and the fourth or fifth leading
cause of death in the developed world [12, 13]. There is
ample data to suggest that presence of MetS intensifies the
risk of developing T2DM to manyfold [14, 15]. “Clustering”
of metabolic abnormalities (hypertension, hyperinsulinemia
hypertriglycemia, hyperglycemia) that occur in the indi-
vidual appears to confer a substantial additional risk for
developing future T2DM, which would add to the 230
million people worldwide who already have diabetes [12, 18].
A prospective cohort study conducted on 2,924 patients
found that the presence of MetS in patients was associated
with a four- to sixfold increased risk of future T2DM [33].
Another study suggested that people with metabolic syn-
drome have a fivefold greater risk of developing T2DM [34].
In this study we found that about 62.8% of the total popu-
lation had impaired fasting glucose, which is an important
indicator to predict T2DM. These results are also consistent
with a study conducted in Africa which concluded that a
large proportion of patients with impaired glucose tolerance
had MetS [30].
Studies have presented contrasting results on the use of
TG/HDL ratio (dyslipidemia) as a marker for MetS [35].
A study conducted in California on 258 diabetic participants
considered TG/HDL ratio as a strong marker of MetS. How-
ever, another study on African Americans showed comple-
mentary result on the use of TG/HDL ratio as an ineﬀective
marker of insulin resistance [35, 36]. Our study results are
congruent with the previous study on African Americans
[36]; we have observed lowHDL level in 53% and an elevated
triglyceride level in only 40%. This finding can also be the
result of ethnic diﬀerences.
The present study reveals that MetS was more common
among the male participants (66%); this finding is contrary
to previous studies which showed a higher prevalence of
MetS among women [37]. This change in results can be due
to the recent urbanization in our society [22], which has
aﬀected males more; as majority of males are now driving
cars that have replaced pedal walking, working on desk-based
oﬃce jobs, sitting at computer for long hours and changing
in dietary pattern, that is, junk food, all these have put people
at risk of more obesity than it could ever be imagined.
Despite the close association between MetS components
and high blood pressure levels, it is diﬃcult to describe the
contribution of each component in the increment of blood
pressure levels. Previously, it has been shown that a high
prevalence of MetS is present among essential hypertensives
than in general population [38]. In Asia Pacific the most
contributing component towards development of MetS was
hypertension [39], but this is contrary to our findings; in our
study 54% of the study participants with uncontrolled blood
pressure had MetS.
The PAMELA study had recently provided us further
data on association of MetS with cardiovascular risk factors
[40]. Although we have described each component of MetS
as an independent risk factor for development of cardio-
vascular disease, the highest prevalence observed was with
a combination of three risk factors, with an extremely low
proportion without any risk factor, that is, 2.6%. Increasing
research over contribution of MetS components in the
development of cardiovascular disease is being done [41].
Several epidemiological studies and clinical medicine had
recognized that family history is a risk factor for many
chronic diseases such as T2DM [42, 43]. Recognition of fam-
ily history is not only useful in predicting genetic suscepti-
bility of an individual to a disease but is also advantageous
for early detection and preventive strategies. Likewise, family
history of diabetes is not only a risk factor but is also
associated with risk-reducing behaviors [42]. It is well known
that T2DM has a strong genetic component and most
patients of T2DM have a first-degree relative with diabetes
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[44]. Many studies have provided evidence for association of
MetS with family history of diabetes [42–44]. A nationally
representative sample of US adults had shown a significant
and positive association between family history of diabetes
and MetS components [44]. Another recent cross-sectional
study conducted by Das et al. in Kolkata, India, on 448
adults has found that those individuals whose parents and
siblings had history of T2DM had more prevalence of MetS
components as compared to their counterparts (P < 0.001)
[45]. This study results are also congruent to other studies as
those patients whose parents and/or their siblings had history
of diabetes were two (AOR: 2.4, 95% CI: 1.0–4.8) and three
times (AOR: 3.0, 95%CI: 1.6–6.0) at risk of developingMetS,
respectively.
Epidemiological studies have considered educational
status as a surrogate measure for socioeconomic status [46,
47]. However, it can roughly predict the job opportunities
and future socioeconomic status. In addition, it plays a vital
role in shaping the attitudes and behavior of individual
towards health. Studies had found inverse and strong rela-
tionship between educational status and presence of MetS
[45–47]. There is obviously no direct association of educa-
tion with MetS but it may influence the life style changes.
A study conducted on 300 women also concluded that the
risk of MetS increases among less educated individuals [48].
This is also consistent with the current study results as the
risk of MetS is 3 times higher in those who have primary-
level education, as compared to those with higher level of
education.
The association of education and socioeconomic status
with MetS was most observed among females as they are
more subjective to socioeconomic inequalities in our conti-
nent [46, 49]. Nevertheless, the health of women in Pakistan
is compromised, since they are not empowered to take their
own decisions and are not allowed to go outside their homes
without accompanying male member of the house [49]. This
leaves them more exposed to sedentary life style and obesity,
precursors of MetS [49]. We do not have the actual income
data of the participants so we cannot comment on the
direction of association between socioeconomic status and
MetS. However we can assume that the population coming
to the study setting would be aﬄuent (through cost of exami-
nation) and their health behavior and attitude are diﬀerent
from the general population, another reason for high pre-
valence of MetS.
4.1. Role of Family Physician. With the rise of epidemics of
type 2 diabetes and CVD worldwide it is important for
family physicians to identify those individuals withmetabolic
syndrome early, so that lifestyle interventions and treatment
may prevent the development of diabetes and/or cardio-
vascular disease. These can be done in three ways; educational
strategies: through information about MetS, its components,
risk factors that are found to be common in Pakistani pop-
ulation; preventive strategies: screening for high risk groups
such as family history of diabetes, obesity, and so forth, pro-
moting life style changes to avoid obesity; pharmacotherapy:
Aggressive pharmacologic management of risk factors in
preventing complications of T2DM.
4.2. Limitations. This study has some limitations. Since this
was a retrospective study so temporal associations cannot
be ruled out. Moreover, we did not have information on
waist circumference of the patients so we could not observe
the association of MetS and abdominal obesity (common
in Pakistani population) in our study. The data has been
extracted from a hospital so extrapolation of the results to the
general population must be done with caution. The data was
gathered from executive clinics so their health-seeking
behavior and patterns can be diﬀerent from those of the gen-
eral population. The missing data in the study were handled
through mean imputation which can distort the association
between the factors.
5. Conclusion
This study from one of the largest cosmopolitan cities of
the world highlights a high prevalence of MetS and its com-
ponents. The presence of such factors among apparently
healthy individuals is a cause of concern and requires the
need for urgent interventions in order to prevent and control
MetS and its associated risk factors such as T2DM and
CVD. These interventions should be based on the integrated
lifestyle approach, keeping in mind the socioeconomic status
of the population. Health care providers should provide
awareness regarding MetS risk factors and its prevention to
patients and their families. Awareness sessions should also
be held to educate the masses through media. Nevertheless,
further research is required to explore this vital issue in detail
and to develop and test the interventions.
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